FY2024 EPS Forecast for Ascend Wellness Decreased by Analyst

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Equities research analysts at Cormark lowered their FY2024 EPS estimates for shares of Ascend Wellness in a report issued on Wednesday, November 13th. Cormark analyst J. Pytlak now expects that the company will post earnings per share of ($0.41) for the year, down from their prior forecast of ($0.35). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Cormark also issued estimates for Ascend Wellness’ FY2025 earnings at ($0.23) EPS.

Ascend Wellness Stock Down 6.8 %

Shares of OTC:AAWH opened at $0.47 on Friday. Ascend Wellness has a 12-month low of $0.42 and a 12-month high of $1.82. The stock’s 50-day moving average price is $0.82 and its two-hundred day moving average price is $0.95. The company has a current ratio of 1.47, a quick ratio of 1.29 and a debt-to-equity ratio of 2.61. The firm has a market cap of $99.66 million, a price-to-earnings ratio of -1.13 and a beta of 1.69.

Ascend Wellness (OTC:AAWH) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). The firm had revenue of $141.65 million for the quarter, compared to analysts’ expectations of $144.13 million. Ascend Wellness had a negative return on equity of 72.18% and a negative net margin of 15.47%.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.